Thank you for sharing!

Your article was successfully shared with the contacts you provided.
Credit reporting agency Experian’s $485 million acquisition of PriceGrabber.com, an online price comparison site, was akin to deja vu for Latham & Watkins Los Angeles partner David Hernand. About seven months ago, Hernand represented LowerMyBills.com in a similar sale to Experian for $380 million. “The lawyers on both sides were exactly the same, which made the deal incredibly efficient,” Hernand said. “It’s always good to have worked with someone before and get along with them. If I can just figure out who Experian is going to acquire next, it will be perfect.” The deal was interesting from a structural standpoint because PriceGrabber.com was organized as a limited liability company � a somewhat unique organization for a technology company. That’s partly because PriceGrabber.com was started with very little outside investment � unlike a lot of tech companies, which use venture capital � and it utilized a traditional corporate structure. “From a deal execution perspective, it’s outside the ordinary and added some additional tax complications,” Hernand said. Other Latham attorneys working on the deal included partners David Boatwright, David Taub and Karen Silverman, and associates Colin Morris, Ryan Hochgesang, Doris Cho, Agnes Gesiko, Laurence Seymour, Yury Kapgan, Joshua Holian and Sydney Smith. Experian was represented by Sonnenschein Nath & Rosenthal partner Neal Aizenstein and associate Eric Mansell. � Kellie Schmitt DEALING WITH INFLUENZA Fenwick & West lawyers just finished work on an investment deal that is expected to deliver a good return while treating influenza. The law firm represented investors Kleiner Perkins Caufield & Byers and Texas Pacific Group when they plunked down $30 million for about 2.2 million BioCryst Pharmaceuticals Inc. shares in a registered direct offering. The money will fund clinical trials of peramivir, an antiviral drug designed to treat seasonal and pandemic strains of influenza. The deal was announced Dec. 16. “It was interesting working on a transaction that could play a role in potentially saving lives,” lead partner Sayre Stevick said. “It could be some good return on investment and could do some good.” Fenwick attorneys said it took less than a week from the time they started drafting the documents until they were ready to be signed. These transactions are always fast, Stevick said, because investors are keen to seal the deal before the stock price drops too much to avoid too big a discount on a publicly traded company. Also on the Fenwick team were partners Gordon Davidson, Jeffrey Vetter, Michael Shuster and Sergio Garcia, and associates Kris Withrow, Michael Brown and Jacob McQuown. Representing BioCryst was Holme Roberts & Owen partner Richard Plumridge and senior counsel Jennifer D’Alessandro. � Petra Pasternak

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Advance® Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]


ALM Legal Publication Newsletters

Sign Up Today and Never Miss Another Story.

As part of your digital membership, you can sign up for an unlimited number of a wide range of complimentary newsletters. Visit your My Account page to make your selections. Get the timely legal news and critical analysis you cannot afford to miss. Tailored just for you. In your inbox. Every day.

Copyright © 2021 ALM Media Properties, LLC. All Rights Reserved.